Key Highlights
- Renée Galá appointed to Dexcom’s Board of Directors, effective March 6, 2025.
- Brings extensive financial, strategic, and operational leadership experience in the life sciences sector.
- Currently serves as President & COO at Jazz Pharmaceuticals, overseeing global business operations.
- Strong track record in financial leadership, international expansion, and business development at high-growth companies.
Source: Business Wire
Notable Quote
“We are excited to announce Renée’s appointment to the Dexcom Board today and benefit from her insights. Renée’s extensive experience guiding global finance and global operations including commercial and R&D to drive growth and create shareholder value provides an excellent fit at this key point in Dexcom’s journey.” – Kevin Sayer, Chairman, President & CEO at Dexcom
Why This Matters
“We are excited to announce Renée’s appointment to the Dexcom Board today and benefit from her insights. Renée’s extensive experience guiding global finance and global operations including commercial and R&D to drive growth and create shareholder value provides an excellent fit at this key point in Dexcom’s journey.” – Kevin Sayer, Chairman, President & CEO at Dexcom
Related

Dexcom Launches New CGM System, Dexcom ONE+, in Europe
Key Highlights Dexcom ONE+ launches in Spain, Belgium, Poland, and the Netherlands, replacing the previous Dexcom ONE sensor in some markets.Designed with input from end users and healthcare professionals, Dexcom ONE+ offers an easy-to-use, effective CGM experience for managing Type 1 or Type 2 diabetes.New features include a highly accurate sensor, the ability to add…

UpScriptHealth Expands Partnership with Dexcom to Broaden Telehealth Access for Diabetes Patients
Key Highlights UpScriptHealth expands partnership with Dexcom after successful pilot program. Telehealth consultations now available on Dexcom.com for Dexcom G6 and G7 CGM systems. 15.8 million Americans in pharmacy deserts benefit from improved CGM access. Dexcom CGMs provide real-time glucose monitoring without finger pricks. Source: Business Wire Notable Quote “We’re proud to partner with…

Dexcom and ŌURA Partner to Transform Metabolic Health Monitoring
Key Highlights Strategic partnership integrates Dexcom glucose data with Oura Ring metrics, including sleep, activity, and stress insights. $75 million investment by Dexcom in ŌURA's Series D funding, valuing ŌURA at over $5 billion. First app integration launching in early 2025, enabling real-time health insights for shared users. Partnership promotes personalized health insights linking glucose…